Microbio announces development of replicating SARS-CoV-2 virus test

Microbio has developed a new type of COVID-19 test that has the potential to determine not only if someone has the virus but also if they are infectious.

Microbio today announced its ground-breaking InfectID-COVID-19-R test which has been independently validated to identify the presence of replication-competent SARS-CoV-2 virus in samples in 45 minutes (post RNA extraction). 

The full press kit and accompanying photographs can be found in this dropbox.

201021_Microbio_Release_Replicating_SARS-CoV-2_test